410 related articles for article (PubMed ID: 10026270)
1. Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.
Lacroix L; Lacoste J; Reddoch JF; Mergny JL; Levy DD; Seidman MM; Matteucci MD; Glazer PM
Biochemistry; 1999 Feb; 38(6):1893-901. PubMed ID: 10026270
[TBL] [Abstract][Full Text] [Related]
2. Site-specific gene modification by PNAs conjugated to psoralen.
Kim KH; Nielsen PE; Glazer PM
Biochemistry; 2006 Jan; 45(1):314-23. PubMed ID: 16388608
[TBL] [Abstract][Full Text] [Related]
3. Triplex-induced recombination and repair in the pyrimidine motif.
Kalish JM; Seidman MM; Weeks DL; Glazer PM
Nucleic Acids Res; 2005; 33(11):3492-502. PubMed ID: 15961731
[TBL] [Abstract][Full Text] [Related]
4. Mutagenesis mediated by triple helix-forming oligonucleotides conjugated to psoralen: effects of linker arm length and sequence context.
Raha M; Lacroix L; Glazer PM
Photochem Photobiol; 1998 Mar; 67(3):289-94. PubMed ID: 9523530
[TBL] [Abstract][Full Text] [Related]
5. Presence of divalent cation is not mandatory for the formation of intramolecular purine-motif triplex containing human c-jun protooncogene target.
Kaushik S; Kaushik M; Svinarchuk F; Malvy C; Fermandjian S; Kukreti S
Biochemistry; 2011 May; 50(19):4132-42. PubMed ID: 21381700
[TBL] [Abstract][Full Text] [Related]
6. Targeted gene knockout mediated by triple helix forming oligonucleotides.
Majumdar A; Khorlin A; Dyatkina N; Lin FL; Powell J; Liu J; Fei Z; Khripine Y; Watanabe KA; George J; Glazer PM; Seidman MM
Nat Genet; 1998 Oct; 20(2):212-4. PubMed ID: 9771719
[TBL] [Abstract][Full Text] [Related]
7. Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.
Rogers FA; Lloyd JA; Tiwari MK
Artif DNA PNA XNA; 2014; 5(1):e27792. PubMed ID: 25483840
[TBL] [Abstract][Full Text] [Related]
8. (A,G)-oligonucleotides form extraordinary stable triple helices with a critical R.Y sequence of the murine c-Ki-ras promoter and inhibit transcription in transfected NIH 3T3 cells.
Alunni-Fabbroni M; Pirulli D; Manzini G; Xodo LE
Biochemistry; 1996 Dec; 35(50):16361-9. PubMed ID: 8973212
[TBL] [Abstract][Full Text] [Related]
9. The development of bioactive triple helix-forming oligonucleotides.
Seidman MM; Puri N; Majumdar A; Cuenoud B; Miller PS; Alam R
Ann N Y Acad Sci; 2005 Nov; 1058():119-27. PubMed ID: 16394131
[TBL] [Abstract][Full Text] [Related]
10. Enhancement and inhibition by 2'-O-hydroxyethyl residues of gene targeting mediated by triple helix forming oligonucleotides.
Kundu M; Nagatsugi F; Majumdar A; Miller PS; Seidman MM
Nucleosides Nucleotides Nucleic Acids; 2003 Oct; 22(10):1927-38. PubMed ID: 14609232
[TBL] [Abstract][Full Text] [Related]
11. Energetics of strand-displacement reactions in triple helices: a spectroscopic study.
Mills M; Arimondo PB; Lacroix L; Garestier T; Hélène C; Klump H; Mergny JL
J Mol Biol; 1999 Sep; 291(5):1035-54. PubMed ID: 10518941
[TBL] [Abstract][Full Text] [Related]
12. Triplex-mediated gene modification.
Schleifman EB; Chin JY; Glazer PM
Methods Mol Biol; 2008; 435():175-90. PubMed ID: 18370076
[TBL] [Abstract][Full Text] [Related]
13. Transcription inhibition induced by modified triple helix-forming oligonucleotides: a quantitative assay for evaluation in cells.
Faria M; Wood CD; White MR; Hélène C; Giovannangeli C
J Mol Biol; 2001 Feb; 306(1):15-24. PubMed ID: 11178890
[TBL] [Abstract][Full Text] [Related]
14. Chemical modification of pyrimidine TFOs: effect on i-motif and triple helix formation.
Lacroix L; Mergny JL
Arch Biochem Biophys; 2000 Sep; 381(1):153-63. PubMed ID: 11019831
[TBL] [Abstract][Full Text] [Related]
15. Targeting DNA with triplex-forming oligonucleotides to modify gene sequence.
Simon P; Cannata F; Concordet JP; Giovannangeli C
Biochimie; 2008 Aug; 90(8):1109-16. PubMed ID: 18460344
[TBL] [Abstract][Full Text] [Related]
16. Sequence and pH effects of LNA-containing triple helix-forming oligonucleotides: physical chemistry, biochemistry, and modeling studies.
Sun BW; Babu BR; Sørensen MD; Zakrzewska K; Wengel J; Sun JS
Biochemistry; 2004 Apr; 43(14):4160-9. PubMed ID: 15065859
[TBL] [Abstract][Full Text] [Related]
17. Triplex formation on DNA targets: how to choose the oligonucleotide.
Vekhoff P; Ceccaldi A; Polverari D; Pylouster J; Pisano C; Arimondo PB
Biochemistry; 2008 Nov; 47(47):12277-89. PubMed ID: 18954091
[TBL] [Abstract][Full Text] [Related]
18. Targeted genome modification via triple helix formation.
Kalish JM; Glazer PM
Ann N Y Acad Sci; 2005 Nov; 1058():151-61. PubMed ID: 16394134
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
[TBL] [Abstract][Full Text] [Related]
20. Potassium-resistant triple helix formation and improved intracellular gene targeting by oligodeoxyribonucleotides containing 7-deazaxanthine.
Faruqi AF; Krawczyk SH; Matteucci MD; Glazer PM
Nucleic Acids Res; 1997 Feb; 25(3):633-40. PubMed ID: 9016606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
